gonorrhea

Apr 30, 2020

FDA Provides Second Clearance for Binx MDx Platform

The FDA cleared the point-of-care Binx io platform for the detection of chlamydia and gonorrhea in male urine specimens.

Feb 11, 2020

New York State Approves Enzo Biochem STI Tests on GenFlex Platform

The GenFlex is a sample-to-result molecular diagnostic platform that includes sample collection, processing, amplification, and detection, the company said.

Dec 12, 2019

Luminostics' Luminescent Particle Lifts Sensitivity in OTC Test Prototypes

Premium

The firm said it is turbocharging the lateral flow format with sensitivity and cost suitable for over-the-counter STI testing.

Nov 19, 2019

Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

The Ithaca, New York-based firm has submitted its molecular diagnostic instrument along with a test to detect chlamydia, gonorrhea, and trichomonas.

Nov 07, 2019

SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

FIND also announced support for projects from Axxin and DNC Dx for point-of-care detection of sexually transmitted infections.

Nov 04, 2019

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Premium

A San Jose, California-based company appears to be the first in the US to routinely offer nanopore sequencing as part of a testing lab service.

Oct 15, 2019

Enzo Biochem Fiscal Q4 Revenues Down 8 Percent

The company said that the decline in revenues reflected lower industry-wide reimbursement rates under PAMA.

Sep 11, 2019

At-Home STI Testing Focus of Newly Standalone Firm Antelope Dx

Premium

Antelope's founder said that being spun off by MyCartis gives his company the focus it needs to launch tests for use in homes and doctors' clinics.

Sep 06, 2019

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

Premium

New resistance tests for Mycoplasma genitalium and gonorrhea could help stave off superbugs, but guidelines and economic factors may hinder adoption.

Aug 27, 2019

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance

Premium

The clearance of the Binx io CT/NG test marks a milestone for the Johns Hopkins University group that funds early-stage development of rapid STI testing.

Menu

FDA Provides Second Clearance for Binx MDx Platform

New York State Approves Enzo Biochem STI Tests on GenFlex Platform

Luminostics' Luminescent Particle Lifts Sensitivity in OTC Test Prototypes

Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Enzo Biochem Fiscal Q4 Revenues Down 8 Percent

At-Home STI Testing Focus of Newly Standalone Firm Antelope Dx

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance

Pages

Breaking News

FDA Issues Emergency Use Authorization for University of Nebraska Medical Center Coronavirus Test

Oxford Immunotec Shares Rise Sharply on Report of $400M Acquisition Offer

Medix Biochemica Acquires US Firms EastCoast Bio, Biostride

HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing

Opti Medical Systems Gets CE Mark for Coronavirus Test Kit

AACC Revises Guidance on Management of Point-of-Care Testing